Human antibody molecules for IL-13

Details for Australian Patent Application No. 2004256976 (hide)

Owner MedImmune Limited

Inventors Shorrock, Celia Patricia; Minter, Ralph Raymond; Monk, Phillip David; Jermutuz, Lutz

Agent FB Rice

Pub. Number AU-B-2004256976

PCT Pub. Number WO2005/007699

Priority 60/573,791 24.05.04 US; 60/487,512 15.07.03 US; 0407315.1 31.03.04 GB; 60/558,216 31.03.04 US

Filing date 15 July 2004

Wipo publication date 27 January 2005

Acceptance publication date 23 December 2010

International Classifications

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 19/04 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/007699 Priority application(s): WO2005/007699

23 December 2010 Application Accepted

  Published as AU-B-2004256976

21 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004256980-Droplet deposition apparatus

2004256962-Thermal infra-red reflective pigments for coatings